Comparison of the Mismatch Repair System between Primary and Metastatic Colorectal Cancers Using Immunohistochemistry
Journal of Pathology and Translational Medicine. 2017;51(2):129-136 
Prognostic and Predictive Values of Mismatch Repair Deficiency in Non-Metastatic Colorectal Cancer
Cancers. 2021;13(2):300
Clinical significance of tumor microsatellite instability and immunohistochemistry for mismatch repair deficiency in colorectal cancers
Current Colorectal Cancer Reports. 2005;1(2):103-109
Immune Checkpoint Inhibitors in Mismatch Repair Proficient/Microsatellite Stable Metastatic Colorectal Cancer Patients: Insights from the AtezoTRIBE and MAYA Trials
Cancers. 2021;14(1):52
Mismatch repair status between primary colorectal tumor and metastatic tumor, a retrospective consistent study
Bioscience Reports. 2019;39(12):
Immune Checkpoint Inhibition in Metastatic Colorectal Cancer Harboring Microsatellite Instability or Mismatch Repair Deficiency
Cancers. 2021;13(5):1149
DNA mismatch repair enzyme immunohistochemistry in colorectal cancer: a comparison of biopsy and resection material
Pathology. 2010;42(5):414-420
Role of the DNA mismatch repair system in the responsiveness of metastatic colorectal cancers to chemotherapy with CPT-11 (irinotecan)
European Journal of Cancer. 2001;37:S299-S300
Prospective Immunohistochemical Analysis of Primary Colorectal Cancers for Loss of Mismatch Repair Protein Expression
Clinical Colorectal Cancer. 2010;9(4):255-259
Update on immunohistochemistry to identify colorectal tumours with deficient DNA mismatch repair function
Diagnostic Histopathology. 2015;21(3):122-130